NOUVASANT PHARMhealth LTD.[Jiangsu,China] Business Type: Manufacturer , Trade Company , Agent , Distributor/WholesalerMain Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , WorldwideExporter: 71% - 80%Certs: FDADescription: Quinine Dihydrochloride Injection 600mg/2ml,Quinine Dihydrochloride 600mg,Quinine Injection
This medication is an antimalarial.It contains quinine and alkaloid extracts of quinine.
It is recommended for the treatmentof severe malaria attacks or where oral therapy is not feasible.
Malaria is a disease caused by amicroscopic parasite (Plasmodium), it is transmitted by mosquito bites and itoccurs in tropical countries. This disease can be serious. It must be detectedand treated promptly.
Quinine remains active onparasites that have become resistant to some other Antimalarial Drugs(especially in chloroquine resistance regions).
If you are a distributor, please inquire with us aboutproduct registration, importing and/or marketing our products in your countryor region.
If you are a consumer, don't hesitate to contactus about more information for this product.